Joseph D Coppock
Overview
Explore the profile of Joseph D Coppock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhuang Y, Coppock J, Haugrud A, Lee J, Messerli S, Miskimins W
Cancers (Basel)
. 2024 Apr;
16(8).
PMID: 38672607
Elevated glucose uptake and production of lactate are common features of cancer cells. Among many tumor-promoting effects, lactate inhibits immune responses and is positively correlated with radioresistance. Dichloroacetate (DCA) is...
2.
Coppock J, Gradecki S, Mills A
Int J Gynecol Pathol
. 2022 May;
42(1):35-42.
PMID: 35512215
Preferentially expressed antigen in melanoma (PRAME) is a cancer testes antigen initially employed as a diagnostic marker for melanoma. Although negative in most normal tissues, its expression has been reported...
3.
Khan I, Gibson-Corley K, Coppock J, Simons A
Head Neck Pathol
. 2022 Mar;
16(3):763-772.
PMID: 35334093
Interleukin-1 alpha (IL-1α) is a cytokine involved in the acute phase immune response and its expression is upregulated in a variety of solid tumors including head and neck squamous cell...
4.
Coppock J, Schneider M, Surrey L, Karakousis G, Maki R, Cooper K
Am J Surg Pathol
. 2022 Mar;
46(9):1309-1313.
PMID: 35288525
The PLEKHH2::ALK fusion is a rarely reported gene fusion identified predominantly in lung adenocarcinomas. Tumors with this fusion have been reported to be of durable response to ALK inhibitors. We...
5.
Volaric A, Zadeh S, Dusenbery A, Coppock J, Dibbern M, Jenkins T, et al.
Am J Clin Pathol
. 2021 Apr;
156(3):478-490.
PMID: 33834192
Objectives: Pathology and laboratory medicine (PALM) services in low- and middle-income countries are essential to combat the increasing prevalence of cancer in addition to providing documentation of cancer types and...
6.
Coppock J, Mills A, Stelow E
Head Neck Pathol
. 2020 Jun;
15(1):163-168.
PMID: 32564273
Despite higher stages at presentation, patients with high-risk (HR) HPV-related (HPV+) head and neck squamous cell carcinomas (HNSCCs) have better survival rates compared to those with non-HPV-related (HPV-) disease. However,...
7.
Coppock J, Dusenbery A, Elghawy O, Fellenstein L, Frierson Jr H, Shildkrot Y
J Am Soc Cytopathol
. 2020 Mar;
9(3):173-176.
PMID: 32113804
Hereditary amyloidosis is a challenging but critical diagnosis, with serious implications with regard to treatment and disease surveillance for both patients and their families. Systemic symptomology is often vague. As...
8.
Coppock J, Volaric A, Mills A, Gru A
Hum Pathol
. 2018 Aug;
82:282-288.
PMID: 30075155
Targeted inhibition of programmed cell death-1 (PD-1) and its ligand (PD-L1) has emerged as first-line therapy for advanced non-small cell lung cancer. Although patients with high PD-L1 expression have improved...
9.
Coppock J, Willis B, Stoler M, Mills A
Cancer Cytopathol
. 2018 Jul;
126(8):533-540.
PMID: 29975461
Background: In situ hybridization for human papillomavirus (HPV) messenger RNA (HPV RNA ISH) recently was introduced as an ancillary tool in the diagnosis of cervical squamous intraepithelial lesions, and can...
10.
Horton W, Stumpf M, Coppock J, Lancaster L, Dalkin A, Liu Z, et al.
J Endocr Soc
. 2017 Dec;
1(9):1150-1155.
PMID: 29264569
Gestational primary hyperparathyroidism (GPHPT) is a rare condition with fewer than 200 cases reported. We present the case of a 21-year-old woman who presented at 10 weeks' gestation with severe...